Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies.

Tintelnot J, Baum N, Schultheiß C, Braig F, Trentmann M, Finter J, Fumey W, Bannas P, Fehse B, Riecken K, Schuetze K, Bokemeyer C, Rösner T, Valerius T, Peipp M, Koch-Nolte F, Binder M.

Mol Cancer Ther. 2019 Apr;18(4):823-833. doi: 10.1158/1535-7163.MCT-18-0849. Epub 2019 Mar 1.

PMID:
30824613
2.

Reply.

Rolinck-Werninghaus C, Trentmann M, Reich A, Lehmann C, Staab D.

Pediatr Allergy Immunol. 2015 Jun;26(4):385-6. doi: 10.1111/pai.12368. No abstract available.

PMID:
25735268
3.

Improved management of childhood atopic dermatitis after individually tailored nurse consultations: A pilot study.

Rolinck-Werninghaus C, Trentmann M, Reich A, Lehmann C, Staab D.

Pediatr Allergy Immunol. 2015 Dec;26(8):805-10. doi: 10.1111/pai.12338. Epub 2015 Feb 12.

PMID:
25643831
4.

[Stomach diseases. Pathogenesis and therapeutic aspects with special regard to therapy with Sucsan-Azulen comp].

Trentmann M.

Fortschr Med. 1974 Nov 14;92(32):1325-8. German. No abstract available.

PMID:
4457439
5.

[Practical experience in testing of various ointment for treatment of the varicose symptom complex].

Kinscher K, Trentmann M.

Landarzt. 1967 Jul 20;43(20):973-7. German. No abstract available.

PMID:
5616143

Supplemental Content

Loading ...
Support Center